Characterization of furazolidone apical-related effects to human polarized intestinal cells

被引:27
作者
De Angelis, I
Vincentini, O
Brambilla, G
Stammati, A
Zucco, F
机构
[1] CNR, Ist Tecnol Biomed, I-00161 Rome, Italy
[2] Ist Super Sanita, Tossicol Comparata & Ecotossicol Lab, I-00161 Rome, Italy
[3] Ist Super Sanita, Lab Med Vet, I-00161 Rome, Italy
关键词
D O I
10.1006/taap.1998.8445
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In studying the effects of furazolidone (FZ) on the human intestinal Caco-2 cell line grown on microporous membrane, we have previously demonstrated a higher toxicity when the compound was administered at the apical (AP) side than at the basolateral (BL) side. Moreover, we have also shown the production, in the intact cells, of a nitroanion radical from FZ by a cytochrome c P450 reductase, The aim of the present study was to investigate which specific cell structures and functions are involved in the observed domain-related toxicity. The relevance of alterations in integrity and selective properties of the intestinal barrier as first-pass site for ingested molecules is also discussed. We have confirmed that, as expected, the Caco-2 cells are protected from FZ injury by a specific inhibitor of the cytochrome c P450 reductase, and we have shown that this protection is more active on the apical side of the cells. In sublethal conditions, FZ causes increased permeability to H-3-mannitol and, to a different extent, to H-3-inulin. Again the effect is higher when the cells are apically exposed. We have thus examined the tight junctions morphology: a disruption of the apical perijunctional actin-bound cytoskeleton was detected by rhodamine-phalloidin staining and microtubule disorganization by antitubulin fluoresceinated antibodies. Again, the effect was more evident when the cells were apically treated with FZ, Preferential transport and accumulation of the compound by active transport mechanisms could be excluded, since transport of FZ was linear and no intracellular accumulation was detected either from the AP and or the BL sides. All together these results may suggest that the AP formation of the active metabolite and its possible reactivity with SH groups of perijunctional microfilaments could be responsible of the higher FZ apical toxicity. This study shows that polarized differentiated cells are very interesting in vitro models to investigate specific cellular domains as targets of toxic effects and to detect subtle changes that may be induced, in absence of cell death, in specialized epithelial layers, (C) 1998 Academic Press.
引用
收藏
页码:119 / 127
页数:9
相关论文
共 40 条
[1]   QUANTITATIVE APPROACHES TO DELINEATE PARACELLULAR DIFFUSION IN CULTURED EPITHELIAL-CELL MONOLAYERS [J].
ADSON, A ;
RAUB, TJ ;
BURTON, PS ;
BARSUHN, CL ;
HILGERS, AR ;
AUDUS, KL ;
HO, NFH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (11) :1529-1536
[2]   PHARMACOLOGY AND TOXICITY OF FURAZOLIDONE IN MAN AND ANIMALS - SOME RECENT RESEARCH [J].
ALI, BH .
GENERAL PHARMACOLOGY, 1989, 20 (05) :557-563
[3]   SODIUM CAPRATE ELICITS DILATATIONS IN HUMAN INTESTINAL TIGHT JUNCTIONS AND ENHANCES DRUG ABSORPTION BY THE PARACELLULAR ROUTE [J].
ANDERBERG, EK ;
LINDMARK, T ;
ARTURSSON, P .
PHARMACEUTICAL RESEARCH, 1993, 10 (06) :857-864
[4]  
ARTURSSON P, 1991, CRIT REV THER DRUG, V8, P305
[5]   EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2) [J].
ARTURSSON, P ;
LINDMARK, T ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1358-1361
[6]   TOXICITY DETERMINED INVITRO BY MORPHOLOGICAL ALTERATIONS AND NEUTRAL RED ABSORPTION [J].
BORENFREUND, E ;
PUERNER, JA .
TOXICOLOGY LETTERS, 1985, 24 (2-3) :119-124
[7]  
BOULENC X, 1993, BIOCHEM PHARMACOL, V46, P1592
[8]   RICIN TOXICITY AND INTRACELLULAR ROUTING IN TUMORAL HT-29 CELLS .2. DIFFERENTIAL RICIN TOXICITY FROM THE APICAL AND BASOLATERAL SURFACES OF DIFFERENTIATED HT-29 CELLS [J].
CHAZAUD, B ;
MURIEL, MP ;
WANTYGHEM, J ;
AUBERY, M ;
DECASTEL, M .
EXPERIMENTAL CELL RESEARCH, 1995, 221 (01) :214-220
[9]   THE INFLUENCE OF PEPTIDE STRUCTURE ON TRANSPORT ACROSS CACO-2 CELLS [J].
CONRADI, RA ;
HILGERS, AR ;
HO, NFH ;
BURTON, PS .
PHARMACEUTICAL RESEARCH, 1991, 8 (12) :1453-1460
[10]   ESTABLISHED CELL-LINES FOR SAFETY ASSESSMENT OF FOOD CONTAMINANTS - DIFFERING FURAZOLIDONE TOXICITY TO V-79, HEP-2 AND CACO-2 CELLS [J].
DEANGELIS, I ;
HOOGENBOOM, LAP ;
HUVENEERSOORSPRONG, MBM ;
ZUCCO, F ;
STAMMATI, A .
FOOD AND CHEMICAL TOXICOLOGY, 1994, 32 (05) :481-488